1-3 of 3
Tali Siegal
Close
Sort by
Journal Articles

Rituximab, Methotrexate, Procarbazine and Lomustine (R-MPL) for the Treatment of Primary CNS Lymphoma

Eyal Lebel, Neta Goldschmidt, Tali Siegal, MD, Alexander Lossos, MD, Moshe Gatt, MD, Alexander Gural, MD, Adir Shaulov, MD, Revital Saban, MD, David Lavie, MD, Boaz Nachmias, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-140949
Published: 2020
Journal Articles

Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report

Clinical Trials & Observations
Sigal Grisariu, Batia Avni, Tracy T. Batchelor, Martin J. van den Bent, Felix Bokstein, David Schiff, Outi Kuittinen, Marc C. Chamberlain, Patrick Roth, Anatoly Nemets, Edna Shalom, Dina Ben-Yehuda, Tali Siegal
Journal: Blood
Blood (2010) 115 (24): 5005–5011.
https://doi.org/10.1182/blood-2009-12-258210
Published: 2010
Journal Articles

Isolated Brain Parenchyma Relapse of Non-Hodgkin’s Lymphoma (NHL): A Descriptive Analysis from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Nancy D. Doolittle, PhD, Lauren Abrey, MD, Tamara Shenkier, Tali Siegal, Jacoline Bromberg, Edward Neuwelt, Carole Soussain, Patrick Johnston, Gerald Illerhaus, David Schiff, Tracy Batchelor, Silvia Montoto, Emanuele Zucca, Dale Kraemer
Journal: Blood
Blood (2006) 108 (11): 2026.
https://doi.org/10.1182/blood.V108.11.2026.2026
Published: 2006